SPONSOR

Rigshospitalet, Denmark

Total Trials

Recruiting

Phases

Phase 2, Phase 3, EARLY_Phase 1

Conditions studied: Vulva Cancer Sentinel Lymph Node Giant Cell Arteritis (GCA)Ischemic Optic Neuropathy NAION - Non-Arteritic Ischemic Optic Neuropathy CLL CNS Tumor, Childhood Ischaemic Heart Disease Prehabilitation Coronary Artery Bypass

Rigshospitalet, Denmark is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Vulva Cancer, Sentinel Lymph Node, Giant Cell Arteritis (GCA), Ischemic Optic Neuropathy.

The trial portfolio spans Phase 2, Phase 3, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Rigshospitalet, Denmark

How many clinical trials has Rigshospitalet, Denmark sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by Rigshospitalet, Denmark, of which 15 are actively recruiting participants. These trials cover conditions including Vulva Cancer, Sentinel Lymph Node, Giant Cell Arteritis (GCA). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Rigshospitalet, Denmark research focus on?

Rigshospitalet, Denmark clinical trials span Vulva Cancer, Sentinel Lymph Node, Giant Cell Arteritis (GCA), Ischemic Optic Neuropathy, NAION - Non-Arteritic Ischemic Optic Neuropathy, and additional conditions. The research pipeline includes Phase 2, Phase 3, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Rigshospitalet, Denmark clinical trial?

To participate in a Rigshospitalet, Denmark trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rigshospitalet, Denmark trials with current recruitment status updated daily.

Rigshospitalet, Denmark

Frequently Asked Questions — Rigshospitalet, Denmark

Clinical Trials by Rigshospitalet, Denmark

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment

Whole Body Metabolism in Children Before and After Treatment of CNS Tumor

CABGpreHAB - a Feasibility Study Protocol

Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection

MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

GO-PLAY - Early Family-Centered Intervention for Infants With High-Risk of Cerebral Palsy

Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects

The Copenhagen Gender Identity Cohort

Whole Body Metabolism in Children With Cerebral Palsy With Low Skeletal Muscle Mass

Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria

Cone-beam CT in the Diagnosis and Surgical Treatment of Otosclerosis.

The NONA-LISA Trial

PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants